Abnormal asymmetric dimethylarginine/nitric oxide balance in patients with documented coronary artery disease: Relation to renal function and homocysteine

Journal of Thrombosis and Thrombolysis

Volumn 23, Issue 3, 2007, Pages 205-211

  Ilhan, Necip ^a   Seckin, Dilara ^a,b   Ilhan, Nevin ^a   Ozbay, Yilmaz ^a  

^a FIRAT UNIVERSITY   (Turkey)

^b FIRAT UNIVERSITY   (Turkey)

Author keywords

ACE; ADMA; CAD; NO; tHcy

Indexed keywords

CREATININE; HOMOCYSTEINE; N(G),N(G) DIMETHYLARGININE; NITRATE; NITRIC OXIDE; NITRITE;

ADULT; AMINO ACID BLOOD LEVEL; ANGIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; CREATININE CLEARANCE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AGED; ARGININE; CASE-CONTROL STUDIES; CORONARY ARTERIOSCLEROSIS; FEMALE; HOMEOSTASIS; HOMOCYSTEINE; HUMANS; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; NITRIC OXIDE;

EID: 34147149712     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-006-9024-5     Document Type: Article

References (27)

1. Furchgot RF, Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373-376
2. Cooke JP, Dzau VJ (1997) Derangements of the nitric oxide synthase pathway, L-arginine, and cardiovascular diseases. Circulation 96:379-382
3. Boger RH, Bode-Boger SM, Szuba A, Tsao PS, Chan JR, Tangphao O, Blaschke TF, Cooke JP (1998) Asymmetric dimethylarginine (ADMA): A novel risk factor for endothelial dysfunction: Its role in hypercholesterolemia. Circulation 98:1842-1847
4. Miyazaki H, Matsuoka H, Cooke JP, Usui M, Ueda S, Okuda S, Imaizumi T (1999) Endogenous nitric oxide synthase inhibitor: A novel marker of atherosclerosis. Circulation 99:1141-1146
5. Leiper J, Vallance P (1999) Biological significance of endogenous methylarginines that inhibit nitric oxide synthases. Cardiovasc Res 43:542-8
6. Surdacki A, Nowicki M, Sandmann J, Tsikas D, Boeger RH, Bode-Boeger SM, Kruszelnicka-Kwiatkowska O, Kokot F, Dubiel JS, Froelich JC (1999) Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension. J Cardiovasc Pharmacol 33:652-658
7. Boger RH, Bode-Boger SM, Thiele W, Junker W, Alexander K, Frolich JC (1997) Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation 95:2068-2074
8. Lu TM, Ding YA, Charng MJ, Lin SJ (2003) Asymmetrical dimethylarginine: a novel risk factor for coronary artery disease. Clin Cardiol 26:458-64
9. Tawakol A, Omland T, Gerhard M, Wu JT, Creager MA (1997) Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation 95:1119-21
10. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340:1111-5
11. Stuhlinger MC, Tsao PS, Her JH, Kimoto M, Balint RF, Cooke JP (2001) Homocysteine impairs the nitric oxide synthase pathway: Role of asymmetric dimethylarginine. Circulation 104:2569-75
12. Ito A, Tsao PS, Adimoolam S, Kimoto M, Ogawa T, Cooke JP (1999) Novel mechanism for endothelial dysfunction: Dysregulation of dimethylarginine dimethylaminohydrolase. Circulation 99:3092-5
13. Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41
14. Chen BM, Xia LW, Zhao RQ (1997) Determination of NG, NG dimethylarginine in human plasma by high-performance liquid chromatography. J Chromatogr 467-471
15. Cortas NK, Wakid NW (1990) Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin. Chim 36:1440-3
16. Reddan DN, Szczech L, Bhapkar MV, Moliterno DJ, Califf RM, Ohman EM, Berger PB, Hochman JS, Van de Werf F, Harrington RA, Newby LK (2005) Renal function, concomitant medication use and outcomes following acute coronary syndromes. Nephrol Dial Transplant 20:2105-2112
17. Böger RH, Bode-Böger SM, Brandes RP, Phivthongngam L, Böhme M, Nafe R, Mügge A, Frölich JC (1997) Dietary L-arginine reduces the progression of atherosclerosis in cholesterol-fed rabbits: Comparison with lovastatin. Circulation 96:1282-1290
18. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A (2000) Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 101:948-954
19. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Münzel T (2001) Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 104:2673-2678
20. Schachinger V, Zeiher AM (2000) Atherosclerosis-associated endothelial dysfunction. Z Kardiol 89(Suppl 9):IX/70-4
21. Vallance P, Leone A, Calver A, Collier J, Moncada S (1992) Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339:572-575
22. Boger RH (2003) The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor. Cardiovasc Res 59:824-33
23. Jonasson TF, Hedner T, Hultberg B, Ohlin H (2003) Hyperhomocysteinaemia is not associated with increased levels of asymmetric dimethylarginine in patients with ischaemic heart disease. Eur J Clin Invest 33:543-9
24. Wang J, Sim AS, Wang XL, Salonikas C, Naidoo D, Wilcken DE (2006) Relations between plasma asymmetric dimethylarginine (ADMA) and risk factors for coronary disease. Atherosclerosis 184(2):383-8
25. Dayoub H, Achan V, Adimoolam S, Jacobi J, Stuehlinger MC, Wang BY, Tsao PS, Kimoto M, Vallance P, Patterson AJ, Cooke JP (2003) Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: Genetic and physiological evidence. Circulation 108:3042-7
26. Griendling KK, FitzGerald GA (2003) Oxidative stress and cardiovascular injAry: Part II: animal and human studies. Circulation 108:2034-2040
27. Bonaa KH, Njolstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, Wang H, Nordrehaug JE, Arnesen E, Rasmussen K (2006) NORVIT Trial Investigators. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 354(15):1578-88